Rankings
▼
Calendar
AMPH Q1 2016 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMPH
Amphastar Pharmaceuticals, Inc.
$860M
Q1 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$59M
Gross Profit
$25M
41.9% margin
Operating Income
$4M
6.9% margin
Net Income
$2M
4.2% margin
EPS (Diluted)
$0.05
Cash Flow
Operating Cash Flow
$14M
Free Cash Flow
$10M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$395M
Total Liabilities
$98M
Stockholders' Equity
$297M
Cash & Equivalents
$63M
Revenue Segments
Finished Pharmaceutical Products Segment
$59M
99%
Active Pharmaceutical Ingredient Segment
$812,000
1%
Geographic Segments
U
$59M
100%
← FY 2016
All Quarters
Q2 2016 →
